Compass Therapeutics (CMPX) Shares Issued (2023 - 2025)
Historic Shares Issued for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $138.0 million.
- Compass Therapeutics' Shares Issued changed N/A to $138.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.0 million, marking a year-over-year increase of 66187.82%. This contributed to the annual value of $18.1 million for FY2024, which is 47943.06% up from last year.
- As of Q3 2025, Compass Therapeutics' Shares Issued stood at $138.0 million.
- In the past 5 years, Compass Therapeutics' Shares Issued ranged from a high of $138.0 million in Q3 2025 and a low of $41000.0 during Q1 2023
- Over the past 3 years, Compass Therapeutics' median Shares Issued value was $10.6 million (recorded in 2023), while the average stood at $39.8 million.
- Within the past 5 years, the most significant YoY rise in Compass Therapeutics' Shares Issued was 4407804.88% (2024), while the steepest drop was 4407804.88% (2024).
- Quarter analysis of 3 years shows Compass Therapeutics' Shares Issued stood at $3.1 million in 2023, then surged by 487.13% to $18.1 million in 2024, then soared by 661.88% to $138.0 million in 2025.
- Its Shares Issued was $138.0 million in Q3 2025, compared to $18.1 million in Q1 2024 and $3.1 million in Q2 2023.